TITLE

Ivax Gains Favorable Ruling in Taxol Dispute

PUB. DATE
September 2000
SOURCE
Chemical Market Reporter;09/11/2000, Vol. 258 Issue 11, p17
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the decision of the United States Food & Drug Administration to de-list the anti-cancer drug paclitaxel of Ivax Corp. Details on the court decision; Validity of the anti-cancer drug patent; Information on the drug patent requirement set by the federal agency.
ACCESSION #
3576134

 

Related Articles

  • Ivax Shores Up Two Additional Paclitaxel Makers.  // Chemical Market Reporter;6/4/2001, Vol. 260 Issue 23, p3 

    Reports on the decision of the United States Food and Drug Administration (FDA) to approve two additional drug makers to manufacture the Onxol or paclitaxel drug of Ivax Corp. Failure of Ivax to meet the increased demand for Onxol; Significance of the FDA decision to Ivax; Pharmaceutical...

  • IVAX GETS FINAL APPROVAL FOR METFORMIN.  // Biotech Business;Mar2002, Vol. 15 Issue 3, p6 

    Reports on the approval received by IVAX Corp. from U.S. Food and Drug Administration for its Abbreviated New Drug Application for sales of metformin hydrochloride tablets.

  • Federal Appeals Court Overturns FDA Approval of Generic Taxol. Hess, Glenn // Chemical Market Reporter;11/12/2001, Vol. 260 Issue 17, p1 

    Reports that the United States (U.S.) Court of Appeals has contested the approval of the U.S. Food & Drug Administration for a generic version of the cancer drug Taxol. Reaction of Ivax Corp., who sells the generic drug paclitaxel, on the ruling of the court; How sales from Taxol contribute to...

  • Ivax's lisinopril gets tentative OK.  // Drug Store News;1/21/2002, Vol. 24 Issue 1, p37 

    Reports the tentative approval by the United States Food and Drug Administration of the lisinopril tablets produced by Ivax. Treatment indication of the drug.

  • Pharma & Fine Chemicals: Market Briefs.  // Chemical Market Reporter;06/28/99, Vol. 255 Issue 26, p14 

    Presents news briefs about the market for pharmaceuticals and fine chemicals. Approval from the United States Food and Drug Administration (FDA) received by Ivax Corporation; Fumaric acid offered by Balchem Encapsulates; FDA's approval of Taro Pharmaceutical Industries Ltd.'s ketoconazole tablets.

  • Ivax gets FDA approval for generic antipsychotic.  // Drug Store News;1/12/98, Vol. 20 Issue 1, pCP14 

    Reports on the US Food & Drug Administration's approval of Ivax Corp.'s abbreviated drug application for clozapine, a generic antipsychotic drug.

  • In the clinic: Where Paclitaxel and Docetaxel stand. McNeil, Caroline // JNCI: Journal of the National Cancer Institute;8/2/95, Vol. 87 Issue 15, p1107 

    Reports on the clinical researches on both paclitaxel (Taxol), manufactured by Bristol-Myers Squibb of Princeton, New Jersey and docetaxel (Taxotere), manufactured by Paris, France-based Rhone-Poulenc Rorer. Approval of Taxol by the US Food and Drug Administration; Clinical researches for both...

  • Psychosis Update.  // PharmaWatch: CNS;Feb2006, Vol. 5 Issue 2, p10 

    The article reports on news and developments concerning the pharmaceutical industry. Ivax Corp. has received a final approval from the U.S. Food and Drug Administration (FDA) for its abbreviated drug application for a 200 milligram dosage clizapine tablet for the treatment of schizophrenia....

  • Generics Watch. Roller, Kim; Frederick, James // Drug Store News;10/16/2000, Vol. 22 Issue 15, p16 

    Presents information on several issues concerning generic drugs in the United States (U.S.). Approval given by the U.S. Food and Drug Administration on release of Taxol drug manufactured by Ivax company for breast and ovarian cancer treatment; Proposed legislation by Senator Charles Schumer...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics